chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme pain and swelling on right arm; Extreme pain and swelling on right arm; Unable to function; Itchy welts appeared on right arm; Extreme headache; I was not able to move with out have extreme pain; Electric shock to the base of my neck halfway down my spine/shock feeling; I had to make gradual moves and not stand or walk; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301538a) via an unspecified route of administration in the right arm on an unknown date in Oct2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient medical history reported as not applicable. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 16Oct2021 at 16:00, the patient experienced extreme pain and swelling on right arm, unable to function, itchy welts appeared on right arm, extreme headache that had an electric shock to the base of her neck halfway down her spine, she was not able to move without had extreme pain and the shock feeling, she had to made gradual moves and not stand or walk. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme pain and swelling on right arm, unable to function, itchy welts appeared on right arm, extreme headache, she was not able to move without had extreme pain, electric shock to the base of her neck halfway down her spine/shock feeling and she had to made gradual moves and not stand or walk was unknown at the time of this report.
Bump; Soreness at injection site; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Bump), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE MASS (Bump), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE MASS (Bump), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.            No concomitant medications were provided.   No treatment details were provided.
fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient got second shot yesterday woke up with a fever and took 2 at 3am and felt like in need of one more.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.
Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER 1/15 AND 2/5/21 WITH PFIZER AND TESTED POSITIVE FOR COVID 8-30-21.  PATIENT WAS HOSPITALIZED 9/2/21 AND WAS TREATED FOR HYPOXIA--HE IMPROVED AND WAS DISCHARGED.
Pregnant patient received second dose; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant patient received second dose) in a 30-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 04L320A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy normal (Live full term birth.) on 11-Aug-2018, Miscarriage (miscarriage approximately in 9 weeks, Spontaneous abortion.) on 14-Aug-2020 and Irritable bowel syndrome in 1990. Concurrent medical conditions included Low blood pressure in 2007. Concomitant products included IRON from 20-Jul-2021 to an unknown date for Anemia, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE], VITAMIN B6, DOXYLAMINE SUCCINATE (UNISOM 2) and FISH OIL for Pregnancy.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 05-Jan-2021 and the estimated date of delivery was 12-Oct-2021. On 26-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant patient received second dose). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  seventh week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 26-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant patient received second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Blood glucose normal: 15jul2021 (normal) normal. On 12-Feb-2021, Pregnancy test: positive (Positive) Positive. On 12-Feb-2021, Ultrasound abdomen normal: 23feb2021 (normal) normal and 04oct2021 (normal) normal.         No treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: significant followup received including medical history, concomitant medication and action taken updated.
09/08/22 vacations for Bivalent Covid booster and flu shot 9/27/22 symptoms of Covid (99.8 fever, coughing, mucus). Positive antigen test 9/28 positive antigen test at urgent care and lab test taken showed  N Gene CT 15.6 critically high. Was given Paxlovid. 10/1 and 10/3 negative antigen Covid tests (recovered).
Within 2 minutes of receiving vaccine, patient reported experiencing throat swelling, face and lip tingling. Patient was administered diphenhydramine PO while in clinic. At this time, patient declined to be seen in the ED and was released from clinic after additional monitoring. Patient received a course of prednisone from another physician later that day. 2 days later the patient began experiencing severe abdominal pain and was seen in the ED.  Labs, right upper quadrant ultrasound, and abdominal CT were within normal limits and was determined that symptoms were likely still part of COVID vaccine anaphylactic reaction. The patient was evaluated by the acute care surgery service who did not find anything concerning and was discharged home from the ED with return precautions and instructions to follow-up with primary physician. The patient follow-up with PCP and was continued on a 5 day course of steroids. The patient will not receive a second vaccine dose at this time and was referred to see an allergist for further testing.
This consumer report (initial receipt 23-Oct-2013) concerns a female patient who had a history of adverse reactions with many unspecified products. On an unspecified date, the patient received a flu vaccine (manufacturer and batch number not reported). The patient concomitantly received CELESTONE SOLUSPAN (batch number not reported). On an unspecified date, after receiving the flu vaccine and the CELESTONE SOLUSPAN, the patient was unable to fall asleep for 55 hours and was also diagnosed with gout. Outcome was not reported.
Child had chronic ear infections from 5 months to 18 months of age. 10 rounds of antibiotics and 1 shot injection. Diagnosed PPD at 2 years 10 months of age.
From one inch below the injection site down to the elbow, swelling and redness. Patient was seen at an urgent care facility one day after symptoms began (2 days after the injection), and started doxycycline as prescribed by the urgent care facility 3 days after the vaccination.
Swollen lymph nodes n her collar bones and neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes n her collar bones and neck) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes n her collar bones and neck). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes n her collar bones and neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event were not provided.  No laboratory investigations were provided. The Treatment information included Ibuprofen, and acetaminophen.
None, dose given out of vial that had been open for more than 6 hours, but kept refrigerated.
Headache very tired, lethargic Narrative:  Received 2nd dose of Covid vaccine at 0730 am on 2/8/21. Felt very tired after shot, slept a lot and hard time waking up this am. "Feelis like I'm is moving in slow motion" and has a headache. Advised that should subside in 24 hours and if it does not and things become worse to follow up PCP  Other Relevant History:
8/16/22 First COVID vaccine, 08/26/22 first R sided focal awareness seizure (3-4 min in duration) and behavioral changes-explosive anger and meltdowns, depression and attention issues which persisted while awaiting 3 months to see a neurologist. 12/27 second R sided focal awareness seizure (5-6 minutes in duration) followed by persistent coordination issues, tremors, R upper and lower extremity weakness which got worse over a two week period. 1/17 MRI showed suspected Acute Disseminated Encephalomyelitis which white and gray matter lesions in brain and spinal cord. Admitted for further testing and treatment. Believed to be a relapse of ADEM with first episode likely in August 2022 at time of first seizure and behavioral changes. Seizures likely due to L sided brain lesion. Corticosteroids given and improvement of weakness, tremors and coordination. Behavioral issues ongoing. On Trileptal for seizures. Will repeat MRI in 3-4 months
After the first vaccine, I had the expected headache, fatigue, slightly sore arm, slight nausea, and headache which lasted a couple of days. I then developed what felt like menstrual cramping and acidic stomach pain, but I hadn't had a menstrual cycle in seven months, and only two in the past two years.  On the 11th day after my vaccination, I had very light bleeding for a day. I didn't connect it to my being vaccinated at all. In the past, I always experienced acidic stomach pain right before my period. I was concerned about cancer so made an OB appointment right away. I didn't see her until two weeks after my second vaccine. I was given the second dose three weeks later on April 21, 2021, and the morning after I had the same side effects as with the first dose--headache, fatigue, slightly sore arm, slight nausea, and headache. Two days later on April 23rd, I began having vaginal bleeding again, only three weeks after the first vaccine. The bleeding was very heavy and lasted for ten days--longer than any vaginal bleeding I'd ever had and much heavier in flow.
Pt developed redness and swelling over most of upper arm where SHINGRIX had been administered. She was seen by a physician who diagnosed it as a "severe allergic reaction" and prescribed a 4 day course of steroids to treat. Pt reported this to me, and still had a slight residual redness on the left upper arm.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurts at the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurts at the injection site). At the time of the report, VACCINATION SITE PAIN (Arm hurts at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported.    Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: No significant follow up; Reporter's Comments: N/A; Sender's Comments: N/A
rash below the injection site; warm to touch on arm below the injection site "COVID ARM; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash below the injection site) and INJECTION SITE ERYTHEMA (warm to touch on arm below the injection site "COVID ARM) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Lumpectomy (breast cancer) (removal of lymph nodes).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced INJECTION SITE RASH (rash below the injection site) and INJECTION SITE ERYTHEMA (warm to touch on arm below the injection site "COVID ARM). At the time of the report, INJECTION SITE RASH (rash below the injection site) and INJECTION SITE ERYTHEMA (warm to touch on arm below the injection site "COVID ARM) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided Treatment information included Ice pack, Benadryl, Tylenol.
Case died of Covid 6 months after completing primary Covid vaccine series.  1 Arrived at hospital with shortness of breath, and a cough, and died in the emergency room. Covid listed as cause of death on death certificate.
no adverse effects noted; the patient received an expired dose of PROQUAD; This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported.  On 02-OCT-2019, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # R008205 (expiration date: 16-SEP-2019), subcutaneously in the left deltoid for prophylaxis. No adverse effects noted.
Bleeding, bruising, and swelling immediately after injection... 12/7 diagnosed with blood clot thought to be due to injection.
pt developed severe itching 1 week after #3 covid vaccine and lasted over one week and did not respond to antihistamines
Child did not experience adverse effects; parents were reached to check on child's health status. No adverse events on the date of vaccine administration or up to 4 days later.
Loss of smell the day after administration (4/10)  Smell returned 4/11 Spotty rash along inner thighs and armpits beginning 4/10 and worsening 4/11 (today)
Patient reports pain to R arm where Prevnar 20 was given. Symptoms started the day after vaccine was given and still continues 2 months later. Patient using Tylenol as needed. Patient reports pain when moving arm not when at rest.
Pt began crying in pain immediately after IZ given and had localized swelling, erythema, and indurated center; no anaphylaxis. Immediately gave BENADRYL 7 ml one-time and took set of repeat vitals; vital signs stable and w/in 10 min of BENADRYL administration, swelling came down. Pt remained in office another 15 minutes w/o further issues.
Severe Fever-like symptoms -- Chills. Disorientation. Cold Sweats. Joint Pain. Stomach Irritation. Nausea.
Narrative:  Breakthrough Covid-19: presents w/ worsening SOB and cough productive of scant clear sputum for ~2 weeks.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 21-MAR-2017  at 15:19, the patient was vaccinated with improperly stored VARIVAX injection (lot # M035142) (expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA00047: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
Patient states felt swelling in throat, not interfering with breathing or swallowing. Throat irritation lasting up to 12 hours. Patient also states "ping-pong" size swelling at or near injection site. Deltoid lasting 3 days.
Information has been received from a woman in a physician's office concerning a 56 year old male who was "negative for rubella". On approx. 4/16/01, the pt was vaccinated with rubella virus vaccine live (second generation). On 4/28/01, the pt experienced a maculopapular rash and was afebrile. No additional information was available. Unspecified medical attention was sought. Additional information has been requested.
arthritis, brain fog, carpal tunnel (today), headaches,  weight gain/ muscle loss, extreme pain under rib cage esp. right side, tinnitis- always had it but seems louder, Charley horse one episode so extreme it felt like a bubble from the leg to the heart felt like a pop then dizziness
I did get "moderna arm" following 2nd dose but it is the aforementioned issues (VASCULAR) with my LEFT EYE and blood clot in LEFT LEG
He is losing vision in his right eye, he might see that with one eye right now and he is losing vision in that eye; the words when he looks at a picture or a sentence it is running of its angle and it is curved; Booster; Interchange of vaccine products; Off Label Use; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 76 year-old male patient received bnt162b2 (BNT162B2), administration date 17Dec2021 10:00 (Batch/Lot number: unknown) at the age of 76 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE) (Batch/Lot number: unknown) as single dose for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Johnson & johnson covid-19 vaccine (1st dose), for Covid-19 immunisation; Johnson & johnson covid-19 vaccine (2nd dose), for Covid-19 immunisation. The following information was reported: BLINDNESS (medically significant) with onset 17Dec2021 13:00, outcome "unknown", described as "He is losing vision in his right eye, he might see that with one eye right now and he is losing vision in that eye"; VISUAL IMPAIRMENT (non-serious) with onset 17Dec2021 13:00, outcome "unknown", described as "the words when he looks at a picture or a sentence it is running of its angle and it is curved". The events were evaluated at the emergency room visit. Therapeutic measures were not taken as a result of blindness, visual impairment. The lot number for bnt162b2 was not provided and will be requested during follow up.
she still has to walk with a cane; chills; pimples came out on her mouth; couldn't even walk; had body aches; felt tired; her arm was hurting; Her arm was hurting, she felt a hard, hot spot, it lasted 3 days; Her arm was hurting, she felt a hard, hot spot, it lasted 3 days; coughing; This is a spontaneous report from a contactable consumer via the medical information team. A 63-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm on 01Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included diabetic and the patient was allergic to certain medicines. The patient's concomitant medications were not reported. On 02Apr2021, the patient arm was hurting, she felt a hard, hot spot, it lasted for 3 days but went away. in the evening, the patient started coughing. On 04Apr2021 in the afternoon, the patient had body aches, couldn't even walk. She wasn't feeling like that before the vaccine. Then she started having chills, pimples came out on her mouth but they were already dried up. The patient was getting better, the cough was worse at night but not bad enough to go to the hospital. The cough was better with remedies. She gets tired when walking but the worst part was already over. For now, the patient still has to walk with a cane, but she did not have any problems before the vaccine. The outcome of the events "her arm was hurting", "Her arm was hurting, she felt a hard, hot spot, it lasted 3 days", had body aches, chills, pimples came out on her mouth was recovered  Information about Batch/Lot number has been requested.